Consolidated Statements of Cash Flows - USD ($)
$ in Thousands |
3 Months Ended |
Apr. 30, 2019 |
Apr. 30, 2018 |
| Cash flows from operating activities: |
|
|
| Net loss |
$ (10,849)
|
$ (5,471)
|
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| Depreciation and amortization expense |
550
|
787
|
| Provision for bad debts |
98
|
|
| Stock-based compensation (credit) expense |
(434)
|
879
|
| Deferred income taxes |
368
|
|
| Unrealized foreign currency transaction gain |
1,207
|
575
|
| Other |
42
|
(7)
|
| Changes in operating assets and liabilities, including impact of acquisitions: |
|
|
| Accounts receivable |
9,870
|
10,449
|
| Unbilled receivables |
(491)
|
(3,571)
|
| Inventory |
166
|
(80)
|
| Prepaid expenses and other current assets and other assets |
(355)
|
224
|
| Accounts payable |
(1,591)
|
(576)
|
| Accrued expenses and other liabilities |
(438)
|
(6,139)
|
| Deferred revenue |
(828)
|
(2,778)
|
| Other operating activities |
|
2,356
|
| Net cash used in operating activities |
(2,685)
|
(3,352)
|
| Cash flows from investing activities: |
|
|
| Purchases of property, plant and equipment |
(50)
|
(113)
|
| Cash paid for acquisitions, net |
(3,838)
|
|
| Purchases of marketable securities |
(6,231)
|
(3,830)
|
| Proceeds from sales and maturities of marketable securities |
6,946
|
2,009
|
| Net cash used in investing activities |
(3,173)
|
(1,934)
|
| Cash flows from financing activities: |
|
|
| Proceeds from issuance of common stock |
9
|
37
|
| Other financing activities |
|
(9)
|
| Net cash provided by financing activities |
9
|
28
|
| Effect of exchange rate on cash and cash equivalents |
229
|
453
|
| Net decrease in cash and cash equivalents |
(5,620)
|
(4,805)
|
| Cash and cash equivalents at beginning of period |
20,317
|
43,661
|
| Cash and cash equivalents at end of period |
14,697
|
38,856
|
| Supplemental disclosure of cash flow information |
|
|
| Income taxes paid |
17
|
$ 182
|
| Non-cash activities: |
|
|
| Purchases of property and equipment included in accounts payable |
19
|
|
| Fair value of common stock issued in acquisition |
$ 874
|
|